Upamostat, CAS [[590368-25-5]]

Produktübersicht

• Artikelname: Upamostat, CAS [[590368-25-5]]
• Artikelnummer: MCE-HY-16511
• Hersteller Artikelnummer: HY-16511
• Alternativnummer: MCE-HY-16511-10MMX1ML,MCE-HY-16511-25MG,MCE-HY-16511-100MG,MCE-HY-16511-5MG,MCE-HY-16511-50MG,MCE-HY-16511-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: WX-671

Produktbeschreibung

Upamostat (WX-671), a prodrug of WX-UK1, is an orally active serine protease inhibitor. Upamostat inhibits the urokinase-type plasminogen activator (uPA) system, blocking the plasminogen activation process mediated by it, thereby suppressing the invasion, migration and metastasis of tumor cells. Upamostat can be used in the research of metastatic breast cancer and locally advanced pancreatic cancer[1].

Produkteigenschaften

• Molekulargewicht: 629.81
• Reinheit: 99.02
• CAS Nummer: [590368-25-5]
• Formel: C32H47N5O6S
• Target-Kategorie: PAI-1,Ser/Thr Protease

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound1